Schedule 13G ownership disclosure

Arcturus Therapeutics Holdings Inc

COMMON STOCK · CUSIP: 03969T109

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Federated Hermes, Inc.

    Shares: 3,303,640.00 · Class: 11.63%

  • Voting Shares Irrevocable Trust

    Shares: 3,303,640.00 · Class: 11.63%

  • Thomas R. Donahue

    Shares: 3,303,640.00 · Class: 11.63%

  • Ann C. Donahue

    Shares: 3,303,640.00 · Class: 11.63%

  • J. Christopher Donahue

    Shares: 3,303,640.00 · Class: 11.63%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001623632-26-000033
Form type
SCHEDULE 13G/A
Filer
Arcturus Therapeutics Holdings Inc.
CIK
CIK 1768224
Filed
Jan 08, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub